« previous next »
Pages: [1]

Author Topic: (Abst.) Teriflunomide in relapsing MS: Outcomes by age, pre-treatment status  (Read 80 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Teriflunomide in relapsing MS: Outcomes by age, pre-treatment status
« on: June 01, 2021, 09:24:59 pm »
Several of the authors here are affiliated with Sanofi-Aventis but here is the abstract.


From Therapeutic Advances in Neurological Disorders (May 18, 2021), "Teriflunnomide in relapsing multiple sclerosis:  Outcomes by age and pre-treatment status":


https://journals.sagepub.com/doi/full/10.1177/17562864211005588
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
225 Views 		Last post September 23, 2017, 04:24:24 pm
by agate
2 Replies
271 Views 		Last post December 26, 2018, 11:56:50 am
by agate
0 Replies
65 Views 		Last post March 07, 2021, 08:50:25 pm
by agate
0 Replies
26 Views 		Last post July 06, 2022, 09:38:32 pm
by agate
0 Replies
3 Views 		Last post March 06, 2024, 08:40:04 pm
by agate